natgillin/translations-raw huggingface dataset:
Dosage is individual and determined by the physician in accordance with the needs of the patient. 
Odmerjanje je individualno in ga dolo i zdravnik skladno z bolnikovimi potrebami.
Side effects reported uncommonly (in less than 1 patient in 100) 
Ob asno opisani neželeni u inki (pri manj kot 1 bolniku na 100)
There are no restrictions on treatment of diabetes with insulin during pregnancy, as insulin does not pass the placental barrier. 
Omejitev za zdravljenje diabetesa z insulinom med nose nostjo ni, ker insulin ne prehaja placentne pregrade.
Velosulin is a fast-acting insulin. 
Velosulin je hitrodelujo i insulin.
Insulin solutions should not be used if they do not appear water clear and colourless. 
Raztopin insulina se ne sme uporabiti, e niso bistre kot voda in brezbarvne.
Not all packs may be marketed. 
Na trgu ni vseh navedenih pakiranj.
If you drive or use tools or machines: watch out for signs of a hypo. 
Vpliv na sposobnost upravljanja vozil in strojev e vozite ali uporabljate orodja ali stroje: pazite na znake hipe.
If repeated or severe low blood glucose levels occur, the patient should notify the health care professional and the need to reduce or stop the insulin administration should be considered. 
e se mo no znižanje koncentracije glukoze v krvi pojavlja ve krat, mora bolnik obvestiti zdravnika in pretehtati je treba potrebo o zmanjšanju ali prekinitvi uporabe insulina.
Before travelling between different time zones, the patient should be advised to consult the physician, since this may mean that the patient has to take insulin and meals at different times. 
Bolniku je treba svetovati, naj se pred potovanjem med razli nimi asovnimi pasovi posvetuje z zdravnikom, saj takšno potovanje lahko pomeni, da bo moral bolnik uporabiti insulin in uživati obroke ob druga nem asu.
Isolated spontaneous cases are presented as very rare defined as <1/10,000 including isolated reports. 
Pogostnosti so opredeljene kot: ob asni (≥ Posamezni spontani primeri so opisani kot zelo redki in opredeljeni kot <1/10.000, vklju no s posameznimi primeri.
• Less exercise than usual. 
• Ste manj telesno dejavni kot ponavadi.
If you get a hypo 
e doživite hipo
10 ml glass vial (type 1) closed with a bromobutyl/polyisoprene rubber stopper and a protective tamper-proof cap. 
10-ml steklena viala (steklo tipa 1), zaprta z brombutil/poliizoprenskim gumijastim zamaškom in zaš itno varnostno zaporko.
The vials that is not being used is to be stored in a refrigerator (2°C - 8°C). 
Viale, ki niso v uporabi, shranjujte v hladilniku (med 2 °C in 8 °C).
Consequently, the time-action profile of an insulin preparation is determined solely by its absorption characteristics. 
Zato asovni potek delovanja pripravka insulina dolo ajo samo njegove absorpcijske lastnosti.
Velosulin must be protected from excessive heat and sunlight. 
Velosulin je treba zaš ititi pred ezmerno toploto in son no svetlobo.
6 weeks when used or stored at room temperature (below 25°C). 
6 tednov, e bolnik uporablja zdravilo ali ga hrani pri sobni temperaturi (do 25 °C).
- The active substance is insulin human made by recombinant biotechnology. 
- Zdravilna u inkovina je humani insulin, pridobljen z rekombinantno biotehnologijo.
A hypo means your blood sugar level is too low. 
Hipa pomeni, da imate prenizek sladkor v krvi.
This process is influenced by several factors (e.g. insulin dosage, injection route and site, thickness of subcutaneous fat, type of diabetes). 
Na to dogajanje vpliva ve dejavnikov (npr. odmerjanje insulina, na in in mesto injiciranja, debelina podkožnega maš evja, tip diabetesa).
If you feel a hypo coming on (a hypo is short for a hypoglycaemic reaction and is a symptom of low blood sugar). 
Znaki alergije so opisani v e utite, da se pojavlja hipa (hipa je okrajšava za hipoglikemi no reakcijo in pomeni simptome nizkega sladkorja v krvi).
If you inject yourself too often at the same site, fatty tissue under the skin at this site may shrink (lipoatrophy) or thicken (lipohypertrophy). 
e insulin prepogosto injicirate na isto mesto, se lahko podkožno maš evje na tem mestu skr i (lipoatrofija) ali zadebeli (lipohipertrofija).
Velosulin is a fast-acting insulin and may be used in combination with certain long-acting insulin products. 
Velosulin je hitrodelujo insulin in se lahko uporablja v kombinaciji z nekaterimi dolgodelujo imi insulinskimi zdravili.
When you start taking insulin, water retention may cause swelling around your ankles and other joints. 
Ko za nete uporabljati insulin, lahko zastajanje vode povzro i otekline okrog gležnjev in drugih sklepov.
Changes at the injection site (Lipodystrophy). 
Spremembe na mestu injiciranja (lipodistrofija).
Severe hypoglycaemia may lead to unconsciousness and/or convulsions and may result in temporary or permanent impairment of brain function or even death. 
konvulzije ali oboje in ima lahko za posledico prehodno ali trajno okvaro delovanja možganov ali celo smrt.
The infusion set should be changed every 48 hours using aseptic technique when inserting the infusion set. 
Infuzijski komplet je treba zamenjati na 48 ur; pri vstavljanju infuzijskega kompleta je treba uporabljati asepti en postopek.
Pack sizes: 1 and 5 vials x 10 ml and a multipack with 5 x (1 x 10 ml) vials. 
Velikost pakiranj: 1 in 5 vial x 10 ml in skupno pakiranje 5 x (1 x 10 ml) vial.
1 ml contains 100 IU of insulin human. 
1 ml vsebuje 100 i.e. humanega insulina.
It is therefore recommended that the diabetic patients carry some sugar lumps, sweets, biscuits or sugary fruit juice. 
Zato je priporo ljivo, da imajo diabeti ni bolniki pri sebi nekaj kock sladkorja, bonbone, piškote ali sadni sok, ki vsebuje sladkor.
Very rare - Anaphylactic reactions 
Zelo redki - anafilakti ne reakcije
• if you suddenly feel unwell and you start sweating; start being sick (vomiting); have difficulty in breathing; have a rapid heart beat; feel dizzy; feel like fainting. 
• se nenadoma slabo po utite in se za nete znojiti, vam postane slabo (bruhate), imate težave z dihanjem, vam srce hitro bije, ste omoti ni, utite omedlevico.
Like all medicines, Velosulin can cause side effects, although not everybody gets them. 
Kot vsa zdravila ima lahko tudi zdravilo Velosulin neželene u inke, ki pa se ne pojavijo pri vseh bolnikih.
As with any insulin therapy, injection site reactions may occur and include pain, itching, hives, swelling and inflammation. 
Kot pri vsakem zdravljenju z insulinom se lahko pojavijo reakcije na mestu injiciranja, med njimi bole ine, srbenje, koprivnica, oteklina in vnetje.
Administration of Velosulin is also possible by subcutaneous or intravenous injection. 
Velosulin je mogo e aplicirati tudi v subkutani ali intravenski injekciji.
Hypersensitivity to the active substance or to any of the excipients (see section 6.1). 
Preob utljivost za zdravilno u inkovino ali katero od pomožnih snovi (glejte poglavje 6.1).
No profound binding to plasma proteins, except circulating insulin antibodies (if present) has been observed. 
Ugotovili niso nobene izrazite vezave na beljakovine v plazmi, razen na krože a protitelesa proti insulinu ( e so prisotna).
• If you exercise more than usual. 
• ste telesno bolj dejavni kot ponavadi.
Symptoms of generalised hypersensitivity may include generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation, reduction in blood pressure and fainting/loss of consciousness. 
Med simptomi generalizirane preob utljivosti so lahko generaliziran izpuš aj na koži, srbenje, znojenje, gastrointestinalne motnje, angionevroti ni edem, težko dihanje, palpitacije, znižanje krvnega tlaka in omedlevica/izguba zavesti.
Side effects reported very rarely (in less than 1 patient in 10,000) 
Neželeni u inki, opisani zelo redko (pri manj kot 1 bolniku na 10.000)
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. 
V razvrstitvah pogostnosti so neželeni u inki navedeni po padajo i resnosti.
Make sure there is no air left in the syringe: point the needle upwards and push the air out Check you have the right dose 
Prepri ajte se, da v brizgi ni ostalo ni zraka: obrnite iglo navzgor in iztisnite zrak.
A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE 
A. IZDELOVALEC BIOLOŠKE ZDRAVILNE U INKOVINE IN IMETNIKI DOVOLJENJA ZA IZDELAVO ZDRAVILA, ODGOVORNI ZA SPROŠ ANJE SERIJE
The best places to give yourself an injection are: the front of your waist (abdomen); your buttocks; the front of your thighs or upper arms. 
Najprimernejša mesta za injiciranje so: sprednji del trebuha (abdomen), zadnjica in sprednji del stegen ali nadlakti.
Renal or hepatic impairment may reduce insulin requirement. 
Okvara ledvic ali jeter lahko zmanjša potrebo po insulinu.
The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating. 
Opozorilni znaki hipe se lahko pojavijo nenadoma in lahko obsegajo: hladno znojenje, hladno in bledo kožo, glavobol, hitro bitje srca, ob utek slabosti, hudo lakoto, prehodne spremembe vida, zaspanost, nenavadno utrujenost in šibkost, živ nost ali tresenje, ob utek tesnobe, ob utek zmedenosti, težave s koncentracijo.
It may occur if the insulin dose is too high in relation to the insulin requirement. 
Pojavi se lahko, e je odmerek insulina prevelik glede na potrebo po insulinu.
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 
Serija: VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT
Use the injection technique advised by your doctor or diabetes nurse 
Za injiciranje uporabite postopek, ki vam ga je svetoval zdravnik ali diabetološka sestra.
If you get any of these signs, test your blood sugar level and test your urine for ketones if you can. Then seek medical advice straight away. 
e se pojavi kateri od teh znakov, si izmerite sladkor v krvi in dolo ite ketone v urinu, e imate to možnost.
Talk about your insulin needs with your doctor and diabetes nurse. 
O svoji potrebi po insulinu se posvetujte z zdravnikom in diabetološko sestro.
Alcohol may intensify and prolong the hypoglycaemic effect of insulin. 
Alkohol lahko stopnjuje in podaljša hipoglikemi ni u inek insulina.
Name and address of the manufacturers responsible for batch release 
Ime in naslov izdelovalcev, odgovornih za sproš anje serije
If you are allergic (hypersensitive) to this insulin product, metacresol or any of the other ingredients (see 7 Further information). 
Ne uporabljajte zdravila Velosulin e ste alergi ni na (preob utljivi za) to insulinsko zdravilo, metakrezol ali kakšno drugo sestavino tega zdravila (glejte poglavje 7.
In type 1 diabetes, untreated hyperglycaemic events eventually lead to diabetic ketoacidosis, which is potentially lethal. 
Pri diabetesu tipa 1 nezdravljene hiperglikemije kon no povzro ijo diabeti no ketoacidozo, ki je lahko smrtna.
The amount or timing of insulin, food or exercise may need to be adjusted. 
Morda bo treba prilagoditi koli ino ali as dajanja insulina, hrano ali telesno
• An infection or a fever 
• Imate okužbo ali zvišano telesno temperaturo.
Solution for injection or infusion in a vial. 
Raztopina za injiciranje ali infundiranje v viali.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, diabetes nurse or pharmacist. 
e kateri koli neželeni u inek postane resen ali e opazite katerikoli neželeni u inek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika, diabetološko sestro ali farmacevta.
Patients whose blood glucose control is greatly improved e.g. by intensified insulin therapy, may experience a change in their usual warning symptoms of hypoglycaemia and should be advised accordingly. 
Bolnikom, ki se jim uravnanost glukoze v krvi zelo izboljša, npr. z intenziviranim insulinskim zdravljenjem, se obi ajni opozorilni simptomi hipoglikemije lahko spremenijo in jih je s to možnostjo treba seznaniti.
Generalised hypersensitivity reactions are potentially lifethreatening. 
Generalizirane preob utljivostne reakcije so lahko smrtno nevarne.
In clinical trials and during marketed use, the frequency varies with patient population and dose regimens. 
Pogostnost v klini nih raziskavah in med uporabo, ko je insulin že na trgu, se spreminja glede na populacijo bolnikov in odmerne sheme.
Concerning compatibility with insulin infusion pumps, reservoirs, catheters and needles, see section 
O združljivosti z insulinskimi infuzijskimi rpalkami, rezervoarji, katetri in iglami glejte poglavje 6.6.
The patient should follow the instructions from the physician about the basal infusion rate and the mealtime insulin boluses to be taken. 
Bolnik mora upoštevati zdravnikova navodila o hitrosti bazalne infuzije in bolusih insulina, ki jih mora uporabiti ob obrokih.
Insulin treatment of the nursing mother presents no risk to the baby. 
Zdravljenje doje e matere z insulinom ne pomeni nobene nevarnosti za dojen ka.
Your need for insulin may change if you also take: oral antidiabetic products; monoamine oxidase inhibitors (MAOI); beta-blockers; ACE-inhibitors; acetylsalicylic acid; anabolic steroids; sulphonamides; oral contraceptives; thiazides; glucocorticoids; thyroid hormone therapy; betasympathomimetics; growth hormone; danazol; octreotide or lanreotide. 
Vaša potreba po insulinu se lahko spremeni, e uporabljate tudi: peroralne antidiabetike; zaviralce monoaminooksidaze (MAOI); zaviralce beta; zaviralce ACE; acetilsalicilno kislino; anabolne steroide; sulfonamide; peroralne kontraceptive; tiazide; glukokortikoide; zdravljenje s šitninimi hormoni; beta-simpatikomimetike; rastni hormon; danazol; oktreotid ali lanreotid.
A pump malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels. 
Nepravilno delovanje rpalke ali zamašitev infuzijskega kompleta lahko povzro i hitro zvišanje koncentracije glukoze v krvi.
Seek medical advice after an injection of glucagon; you need to find the reason for your hypo to avoid getting more. 
Po injekciji glukagona poiš ite zdravniško pomo : ugotoviti morate razlog za hipo, da jih ne boste doživeli še ve .
Intravenous administration should only be carried out by health care professionals. 
Intravensko aplikacijo lahko izvede le medicinsko osebje.
• Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products. 
• Blage hipoglikemije je mogo e zdraviti z zaužitjem glukoze ali sladkih izdelkov.
If you get any of these signs, eat glucose tablets or a high sugar snack (sweets, biscuits, fruit juice), then rest. 
e se pojavi kateri od teh znakov, zaužijte tablete glukoze ali prigrizek, ki vsebuje veliko sladkorja (bonbone, piškote, sadni sok), in nato po ivajte.
Uncommon - Urticaria, rash 
Ob asni - urtikarija, izpuš aj
After first use as infusion: the insulin solution may be stored in the pump reservoir at up to 37°C (close to the body). 
Po prvi uporabi v infuziji: raztopina insulina lahko ostane v rezervoarju rpalke pri temperaturi do 37 °C (blizu telesa).
Long-term improved glycaemic control decreases the risk of progression of diabetic retinopathy. 
Dolgoro no izboljšana urejenost glikemije zmanjša tveganje za napredovanje diabeti ne retinopatije.
Velosulin may also be administered intravenously in special situations by medical professionals. 
Intravensko aplikacijo zdravila Velosulin lahko v posebnih primerih izvede le medicinsko osebje.
Beta-blocking agents may mask the symptoms of hypoglycaemia and delay recovery from hypoglycaemia. 
Zaviralci beta lahko prikrijejo simptome hipoglikemije in upo asnijo okrevanje po njej.
When filling a new syringe, no large air bubbles should be left in either the syringe or the catheter. 
Pri polnitvi nove brizge ne sme ne v brizgi ne v katetru ostati velikih zra nih mehur kov.
Velosulin should not be mixed with insulin zinc suspensions since the phosphate buffer may interact with the zinc in the suspension and alter the timing of action of the insulin in an unpredictable way. 
Zdravila Velosulin se ne sme mešati s suspenzijami insulina s cinkom, ker lahko fosfatni pufer reagira s cinkom v suspenziji, kar nepredvidljivo spremeni asovni potek delovanja insulina.
The blood glucose lowering effect of insulin is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. 
Delovanje insulina na znižanje glukoze v krvi je posledica lažjega prehoda glukoze zaradi vezave insulina na receptorje na miši nih in maš obnih celicah ter hkratne inhibicije sproš anja glukoze iz jeter.
Solusion for injection or infusion 5 x (1 x 10 ml) 
Raztopina za injiciranje ali infundiranje 5 x (1 x 10 ml)
Follow the instructions and recommendations from your doctor regarding the use of Velosulin in a pump. 
Upoštevajte zdravnikova navodila in priporo ila o uporabi zdravila Velosulin v rpalki.
Octreotide/lanreotide may both decrease and increase insulin requirement. 
Oktreotid/lanreotid lahko potrebo po insulinu zmanjša ali zve a.
Before use: store in a refrigerator (2°C - 8°C). 
Pred uporabo: shranjujte v hladilniku (med 2 °C in 8 °C)!
This phosphate-buffered soluble insulin is intended for continuous subcutaneous insulin infusion (CSII) in external insulin infusion pumps. 
S fosfatom pufrani topni insulin je namenjen za stalno subkutano infuzijo insulina v zunanjih insulinskih infuzijskih rpalkah.
Therefore, no specific frequency can be presented. 
Natan ne pogostnosti ni mogo e navesti.
You can keep it in the pump reservoir for 6 days at up to 37°C (close to the body). 
V rezervoarju rpalke lahko imate zdravilo 6 dni pri temperaturi do 37°C (v bližini telesa).
Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to reproduction. 
Neklini ni podatki na podlagi obi ajnih študij farmakološke varnosti, toksi nosti pri ponavljajo ih odmerkih, genotoksi nosti, kancerogenega potenciala in vpliva na sposobnost razmnoževanja ne kažejo posebnega tveganja za ljudi.
Eat a meal or snack containing carbohydrates within 30 minutes of administration. 
V 30 minutah po uporabi pojejte obrok ali prigrizek, ki vsebuje ogljikove hidrate.
Uncommon - Peripheral neuropathy 
Ob asni - periferna nevropatija
Continuous subcutaneous insulin infusion (CSII) in external insulin infusion pumps is usually administered in the abdominal wall. 
Stalna subkutana infuzija insulina v zunanjih rpalkah za infundiranje insulina se ponavadi aplicira v trebušno steno.
Name and address of the manufacturer of the biological active substance 
Ime in naslov izdelovalca biološke zdravilne u inkovine
A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURING AUTHORISATION 
A. IZDELOVALEC BIOLOŠKE ZDRAVILNE U INKOVINE IN IMETNIKI DOVOLJENJA ZA IZDELAVO ZDRAVILA,
Each vial has a protective, tamper-proof plastic cap. 
Vsaka viala ima zaš itno, varovalno plasti no zaporko.
However, intensification of insulin therapy with abrupt improvement in glycaemic control may be associated with temporary worsening of diabetic retinopathy. 
Vendar lahko intenziviranje insulinskega zdravljenja s hitrim izboljšanjem urejenosti glikemije spremlja prehodno poslabšanje diabeti ne retinopatije.
Solusion for injection or infusion 1 x 10 ml 
Raztopina za injiciranje ali infundiranje 1 x 10 ml
They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath. 
Vklju ujejo žejo, pogostejše uriniranje, navzejo, bruhanje, zaspanost, pordelo suho kožo, suha usta, izgubo apetita in acetonski zadah.
In patients with diabetes mellitus optimised glycaemic control delays the onset of late diabetic complications. 
im boljša glikemi na urejenost pri bolnikih z diabetesom mellitusom odloži nastanek poznih diabetinih zapletov.
The terminal half-life is determined by the rate of absorption from the subcutaneous tissue. 
Terminalni razpolovni as je dolo en s hitrostjo absorpcije iz podkožnega tkiva.
Oral hypoglycaemic agents (OHA), monoamine oxidase inhibitors (MAOI), non-selective betablocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol, anabolic steroids or sulphonamides. 
Peroralni antidiabetiki, zaviralci monoaminoksidaze (MAOI), neselektivni zaviralci adrenergi nih receptorjev beta, zaviralci angiotenzinske konvertaze (ACE), salicilati, alkohol, anabolni steroidi in sulfonamidi.
Glycerol 
OVOJNINAH
PARTICULARS TO APPEAR ON THE PACKAGING OUTER WRAPPER LABLE ON MULTIPACKS 
PODATKI NA OVOJNINI NALEPKA ZUNANJEGA OVOJA MULTIPLIH PAKIRANJ
Due to the lack of long-acting insulin, patients receiving continuous subcutaneous insulin infusion via an insulin pump are at risk of fast development of ketoacidosis in case of prolonged interruption of continuous subcutaneous insulin infusion. 
Zaradi odsotnosti dolgodelujo ega insulina bolnike, ki dobivajo stalno subkutano infuzijo insulina z insulinsko rpalko, ogroža hiter nastanek ketoacidoze, e je stalno subkutano infundiranje insulina dalj asa prekinjeno.
Patients using CSII may be more prone to infection at the site of infusion. 
Bolniki, ki uporabljajo stalno subkutano infuzijo insulina, so lahko bolj nagnjeni k okužbi na infuzijskem mestu.
After first use as infusion, the insulin solution may be stored in the pump reservoir for six days at up to 37°C (close to the body). 
Po prvi uporabi v infuziji lahko raztopina insulina ostane v rezervoarju rpalke šest dni pri temperaturi do 37 °C (blizu telesa).
What Velosulin contains 
Kaj vsebuje zdravilo Velosulin
The thigh, the gluteal region or the deltoid region may also be used. 
Uporabiti pa je mogo e tudi stegno, glutealni predel ali deltoidni predel.
Novo Allé, DK-2880 Bagsværd, Denmark 
Novo Nordisk A/S Novo Allé, DK-2880 Bagsværd, Danska
WHAT VELOSULIN IS AND WHAT IT IS USED FOR Velosulin is human insulin to treat diabetes. 
Velosulin je humani insulin za zdravljenje diabetesa.
Upon mixing Velosulin with infusion fluids an unpredictable amount of insulin will be absorbed to the infusion material. 
Po mešanju Velosulina s teko inami za infundiranje se nepredvidljiva koli ina insulina adsorbira na infuzijski material.
Always vary the sites you inject, to avoid lumps (see 5 Possible side effects). 
Mesta injiciranja vedno menjajte, da boste prepreili nastanek zatrdlin (glejte poglavje 5.
When two types of insulin are mixed, draw the amount of fast-acting insulin first, followed by the amount of long-acting insulin. 
V primeru mešanja dveh vrst insulinov je najprej treba izvle i odmerek hitrodelujo ega insulina in potem odmerek dolgodelujo ega insulina.
If the patient suspects an interruption to insulin flow the patient should notify the health care professional. 
e bolnik posumi, da je dotok insulina prekinjen, mora obvestiti zdravnika.
Both hypoglycaemia and hyperglycaemia, which can occur in inadequately controlled diabetes therapy, increase the risk of malformations and death in utero. 
Med nezadostno urejenim zdravljenjem diabetesa se lahko pojavita hipoglikemija in hiperglikemija, ki obe zve ujeta tveganje za malformacije in smrt in utero.
Uncommon - Refraction disorders 
Ob asni - refrakcijske motnje
When combination with long-acting insulin is necessary it is only possible to mix Velosulin with isophane or premixed insulin products. 
e je potrebna kombinacija z dolgodelujo imi insulini, je Velosulin mogo e mešati le z izofanim insulinom ali mešanimi insulini.
Check the label to make sure it is the right type of insulin Disinfect the rubber membrane with a medicinal swab. 
Preden uporabite Velosulin preverite nalepko, da se boste prepri ali, ali imate pravo vrsto insulina; dezinficirajte gumijasto membrano z medicinskim zložencem.
If you are pregnant, planning a pregnancy or breast-feeding: please contact your doctor for advice. 
Nose nost in dojenje e ste nose i, nameravate zanositi ali dojite: za nasvet prosite svojega zdravnika.